Clinical Trial Update: Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and pharmacodynamic effects of PUR118 in chronic obstructive pulmonary disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PUR118 (PUR118)

Snippet

Sponsor: Pulmatrix Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED